Design of 1-(furan-2-yl)-N-(5-substituted phenyl-1, 3, 4-thiadiazol-2-yl) methanimine derivatives as Enoyl-ACP reductase inhibitors: Synthesis, molecular docking studies and antitubercular activity
DOI:
https://doi.org/10.3329/bjp.v8i3.14778Keywords:
KeEnol-ACP reductase, Molecular docking, 1, 3, 4-thiadiazoleAbstract
A series of 5-phenylsubstiuted 1, 3, 4 thiadiazoles clubbed with furan moiety (Fa-Fe) by means of azomethine linkage have been synthesized. All the newly synthesized compounds were characterized by IR,1HNMR and Mass analyses. All the synthesized molecules have been predicted as antitubercular in nature by PASS in silico approach. In vitro antitubercular screening was performed by alamar blue assay method on Mycobacterium tuberculosis H37Rv strain. Among the synthesized derivatives Fb and Fe were active at 3.125 µg/mL against M. tuberculosis H37Rv strain. The mechanism of action of the active compounds was carried out by docking of receptor enoyl-ACP reductase. It has been concluded that both Fb and Fe posses a significant interaction of hydrogen bonding and electrostatic attraction with Tyr 158 and Met103 in the active site of enzyme.
Downloads
346
213 Read
5
References
Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, Collins D, de Lisle G, Jacobs WR Jr. InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994; 263: 227-30.
Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother. 1997; 41: 1004-09.
Gaballa AS, Asker MS, Barakat AS, Teleb SM. Synthesis, characterization and biological activity of some platinum (II) complexes with Schiff bases derived from salicylaldehyde, 2-furaldehyde and phenylenediamine. Spectrochim Acta A. 2007; 67: 114-21.
Hranjec M, Starcevic K, Pavelic SK, Lucin P, Pavelic K, Karminski ZG. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles. Eur J Med Chem. 2010; 46: 2274-79.
He X, Alian A, Stroud R, Montellano PRO. Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. J Med Chem. 2006; 49: 6308-23.
Jatav V, Mishra P, Kashaw S, Stables JP. Synthesis and CNS depressant activity of some novel 3-[5-substituted1, 3, 4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. Eur J Med Chem. 2008; 43: 135-41.
Kolattukudy PE, Fernandes ND, Azad AK, Fitzmaurice AM, Sirakova TD. Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria. Mol Microbiol. 1997; 24: 263-70.
Kuo MR, Morbidoni HR, Alland D, Sneddon SF, Gourlie BB, Staveski MM, Leonard M, Gregory JS, Janjigian AD, Yee C, Musser JM, Kreiswirth B, Iwamoto H, Perozzo R, Jacobs WRJr, Sacchettini JC, Fidock,DA. Targeting tuberculosis and malaria through inhibition of enoyl reductase: Compound activity and structural data. J Biol Chem. 2003; 278: 20851-59.
Laurie AT, Jackson RM. Bioinformatics. Q-SiteFinder: An energy-based method for the prediction of protein-ligand binding sites. 2005; 21: 1908-16.
Mathew B, Suresh AJ, Mathew GE, Shankar S, Kumar SS. Synthesis, characterisation, and anti microbial screening of some 2-amino,5-(phenyl substituted)1,3,4-thiadiazole derivatives. Indian J Chem Tech Res. 2011; 3: 364-68.
Mathew B, Suresh J, Anbazhagan S. Development of novel (1-H) benzimidazole bearing pyrimidine-trione based MAO-A inhibitors: Synthesis, docking studies and antidepressant activity. J Saudi Chem Soc. 2012.
Mathew B, Suresh J, Anbazhagan S. Synthesis and PASS-assisted in silico approach of some novel 2-substituted benzimidazole bearing a pyrimidine-2, 4, 6(trione) system as mucomembranous protector. J Pharm Bioall Sci. 2013; 5: 39-43.
Mathew B, Suresh J, Anbazhagan S, Chidambaranathan N. Discovery of some novel imines of 2-amino, 5-thio, 1, 3, 4-thiadiazole as mucomembranous protector. Synthesis, anti-oxidant activity and in silico PASS approach. J Saudi Chem Soc. 2013.
Poroikov VV, Filimonov DA. How to acquire new biological activities in old compounds by computer prediction? J Comput Aided Mol Des. 2002; 16: 819-24.
Rajendran G, Amritha CS, Anto RJ, Cheriyan VT. Synthesis, thermal and antitumour studies of Th(IV) complexes with furan-2-carboxaldehyde4-phenyl-3-thiosemicarbazone. J Serb Chem Soc. 2010; 75: 749-61.
Sonia G, Ravi TK. Oxadiazolo pyrrolidine carboxamides as enoyl-ACP reductase inhibitors: Design, synthesis and antitubercular activity screening. Med Chem Res. 2012.
Thomas KD, Adhikari AV, Chowdhury IH, Sandeep T, Mahmood R, Bhattacharya B, Sumesh E. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties. Eur J Med Chem. 2011; 46: 4834-45.
Varandas LS, Fraga CAM, Miranda ALP, Barreiro EJ. Design, synthesis and pharmacological evaluation of new nonsteroidal anti-inflammatory 1,3,4-thiadiazole derivatives. Lett Drug Des Discov. 2005; 2: 62-67.
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
